Looking to publish in Nature Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowNature Medicine is a medical journal publishing research, reviews, analysis, news and comment on translational and clinical research across medicine.
Looking to publish in Nature Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Nature Medicine accepts the following article types. Click on an article type to view submission instructions.
Article
Brief Communication
Resource
Analysis
Review
Correspondence
Recent Publications
Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial
D. J. van Veldhuisen, M. Rienstra, A. Mosterd, M. Alings, A. A. Voors, K. Damman, A. D. I. van Asselt, M. L. Bouvy, J. Schaap, E. E. van der Wall, H. J. G. M. Crijns, D. J. Touw, P. A. M. Hoogslag, J. E. C. van de Swaluw, R. J. Schuurman, A. van der Sluis, O. Bondarenko, T. J. Römer, T. Oosterhof, G. L. Bartels, S. Koudstaal, P. A. Dijkmans, G. C. M. Linssen, I. Aksoy, H. G. R. Dorman, A. Schut, M. E. W. Hemels, R. G. Tieleman, D. J. A. Lok, I. C. D. Westendorp, M. A. T. Vijver, G. H. D. Voordes, A. H. de Vos, E. L. Maas-Soer, D. Postmus, G. Lunter, J. G. P. Tijssen, P. van der Meer
The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial
Johann Bauersachs, Scott D. Solomon, Stefan D. Anker, Isabel Antorrena-Miranda, Rudolf A. de Boer, Gerasimos Filippatos, Tim Friede, Wilfried Hauke, Piotr Ponikowski, Orly Vardeny, Rebecca Altschul, Michael Gamborg, Kasper Vinther, Thomas Thum
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals
Brendon L. Neuen, Rupert W. Major, Morgan E. Grams, Yingying Sang, Josef Coresh, Shoshana H. Ballew, Aditya Surapaneni, Natalia Alencar de Pinho, Johan Arnlov, Clare Arnott, Samira Bell, Jarett Berry, Hermann Brenner, Elizabeth Ciemins, Alexander R. Chang, Mary Cushman, James A. de Lemos, Juan Miguel Diaz-Tocados, Alfredo E. Farjat, Robert A. Fletcher, Ron T. Gansevoort, Hiddo J. L. Heerspink, William G. Herrington, Chuan Hong, Edward J. Horwitz, Shih-Jen Hwang, Simerjot K. Jassal, Philip A. Kalra, Ronit Katz, Sadiya S. Khan, Csaba P. Kovesdy, Florian Kronenberg, Jennifer S. Lees, Donald M. Lloyd-Jones, Jose Geraldo Mill, David M. J. Naimark, Chiadi Ndumele, Kevan R. Polkinghorne, Bruce M. Psaty, Patrick Schloemer, Michael Shlipak, Prabin Shrestha, Zean Song, Natalie Staplin, Dominik Steubl, Priya Vart, Frank L. J. Visseren, Mark Woodward, Kazumasa Yamagishi, Bessie A. Young, Charumathi Sabanayagam, Jose M. Valdivielso
Autonomous pathology research using agentic AI shows potential in oncology
-
Frequently asked questions
How long does it take to publish?
Median time from submission to first editorial decision is 4 days. Median time from submission to acceptance is 117 days.
Reformat to Nature Medicine using Livewrite PremiumIs a cover letter required?
A cover letter is expected for revised manuscripts invited for revise and resubmit and should provide any additional information requested by the editors.
Reformat to Nature Medicine using Livewrite PremiumWhat are the publication costs?
Article Processing Charge applies for gold open access articles when the manuscript is accepted; subscription publishing is also available for eligible article types.
Reformat to Nature Medicine using Livewrite Premium